Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T12:46:31.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.
    Difference
    0.7%
    Check dated 2026-10-26T15:53:24.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:50:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T04:22:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The history now includes a new site revision (v3.7.0) replacing the previous revision (v3.6.6). This indicates a UI/system update rather than changes to the study record data.
    Difference
    0.1%
    Check dated 2026-09-21T22:36:50.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 has been added to the Record History. This updates the page's version log and supersedes the previous v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-08-31T17:22:46.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.